These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27098186)

  • 1. Intracranial Hemorrhage as the First Manifestation of Severe Congenital Factor X Deficiency in a 20-Month-Old Male: Case Report and Review of the Literature.
    Diesch T; von der Weid NX; Schifferli A; Kühne T
    Pediatr Blood Cancer; 2016 Jul; 63(7):1300-4. PubMed ID: 27098186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma-derived Factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report.
    Grottke O; Moser O; Farrag A; Elbracht M; Orlikowsky T; Trepels-Kottek S
    Transfusion; 2019 Jul; 59(7):2228-2233. PubMed ID: 30964547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor X deficiency and intracranial bleeding: who is at risk?
    Rauch R; Girisch M; Wiegand G; Schroeder W; Hofbeck M; Welisch E; Wulff K
    Haemophilia; 2011 Sep; 17(5):759-63. PubMed ID: 21682820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe congenital factor X deficiency with intracranial bleeding in two siblings.
    Ermis B; Ors R; Tastekin A; Orhan F
    Brain Dev; 2004 Mar; 26(2):137-8. PubMed ID: 15036435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous Factor X gene mutations Gly380Arg and Tyr163delAT are associated with perinatal intracranial hemorrhage.
    Herrmann FH; Navarette M; Salazar-Sanchez L; Carillo JM; Auerswald G; Wulff K
    J Pediatr; 2005 Jan; 146(1):128-30. PubMed ID: 15644837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran.
    Karimi M; Vafafar A; Haghpanah S; Payandeh M; Eshghi P; Hoofar H; Afrasiabi A; Gerdabi J; Ardeshiri R; Menegatti M; Peyvandi F
    Haemophilia; 2012 Mar; 18(2):211-5. PubMed ID: 21854511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of inherited factor X deficiency.
    Brown DL; Kouides PA
    Haemophilia; 2008 Nov; 14(6):1176-82. PubMed ID: 19141158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmortem diagnosis of severe factor X deficiency in a fetus with intracranial hemorrhage resulting in intrauterine death.
    Krumb E; Mehta N; Hutchinson C; Jradeh B; Jaslowska E; Gomez K; Abdul-Kadir R
    J Thromb Haemost; 2023 Dec; 21(12):3501-3507. PubMed ID: 37678549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.
    Zimowski KL; McGuinn CE; Abajas YL; Schultz CL; Kaicker S; Batsuli G
    J Thromb Haemost; 2020 Oct; 18(10):2551-2556. PubMed ID: 32613702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate.
    Liesner R; Akanezi C; Norton M; Payne J
    Haemophilia; 2018 Nov; 24(6):941-949. PubMed ID: 29707881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and prophylactic use of FEIBA in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report.
    Shim YJ; Won DI
    Haemophilia; 2013 Nov; 19(6):e364-7. PubMed ID: 23902347
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain.
    Todd T; Perry DJ; Hayman E; Lawrence K; Gattens M; Baglin T
    Haemophilia; 2006 Nov; 12(6):621-4. PubMed ID: 17083512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety.
    Shapiro A
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):97-104. PubMed ID: 27797267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene.
    Herrmann FH; Auerswald G; Ruiz-Saez A; Navarrete M; Pollmann H; Lopaciuk S; Batorova A; Wulff K;
    Haemophilia; 2006 Sep; 12(5):479-89. PubMed ID: 16919077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial hemorrhage in congenital bleeding disorders.
    Tabibian S; Motlagh H; Naderi M; Dorgalaleh A
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):1-11. PubMed ID: 28901996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.
    Togashi T; Nagaya S; Nagasawa M; Meguro-Horike M; Nogami K; Imai Y; Kuzasa K; Sekiya A; Horike SI; Asakura H; Morishita E
    Int J Hematol; 2020 Jan; 111(1):51-56. PubMed ID: 31667683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency.
    Kankirawatana S; Mahasandana C; Veerakul G; Seeloem J; Suwantol L; Tanphaichitr V; Suvatte V
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):795-800. PubMed ID: 11414431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial haemorrhage in patients with congenital haemostatic defects.
    Mishra P; Naithani R; Dolai T; Bhargava R; Mahapatra M; Dixit A; Seth T; Kumar R; Saxena R
    Haemophilia; 2008 Sep; 14(5):952-5. PubMed ID: 18637845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial Hemorrhage: A Devastating Outcome of Congenital Bleeding Disorders-Prevalence, Diagnosis, and Management, with a Special Focus on Congenital Factor XIII Deficiency.
    Alavi SER; Jalalvand M; Assadollahi V; Tabibian S; Dorgalaleh A
    Semin Thromb Hemost; 2018 Apr; 44(3):267-275. PubMed ID: 28898896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.
    Dejhansathit S; Suvannasankha A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619832332. PubMed ID: 30947547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.